Melrose Park, IL
Do you have a developed parenteral injectable product in glass vials (2-200 mL), and are you looking for a high throughput facility to partner with for Phase 3 and/or commercialization? Then, the Fresenius Kabi Melrose Park site is for you. Melrose Park is a suburb of Chicago and is located five miles away from the O‘Hare International Airport. The facility has more than 12 years history within Fresenius Kabi, and currently produces a wide range (250 finished products) of parenteral injectable medicines for the treatment of critically and chronically ill patients.
The new facility is equipped with a state-of-the-art urban manufacturing campus, fully-automated aseptic filling lines and advanced isolator technology, as well as expanded lyophilization capabilities and formulation areas.
Fresenius Kabi is currently completing a $ 250 million investment project to expand capacities at its Melrose Park site with annual capacities in future of more than 250 million units.
Multiple integrated aseptic filling lines in connection with lyophilizers with automated loading are being installed in the expansion, including one cytotoxic line, one highpotent/ hormone line and multiple general product lines to increase overall manufacturing capacities. This additional capacitity will significantly enhance the annual output as of today, with multiple aseptic lines and lyophilizers in place in the existing site for the supply of life-saving drugs filled in vials for distribution in the U.S. and Canada.
We offer also filling and finishing services for highly potent products in a multiproduct facility using effective separation with smart HVAC and architecture design and new disposable single-use system technologies with fully disposable and/or dedicated product contact parts for the reduced risk of cross contamination.
Additionally, we offer technologies required for filling advanced complex parenterals such as emulsion processing, cold filling, oxygen reduction, metal–sensitive, and other sophisticated technologies.
The site is also home to GMP compliant semi-automated and automated inspection processes, and five packaging lines, two of which are fully automated, and all are installed with serialization and aggregation equipment to meet DSCSA requirements.
We are committed to sustainable production, with certification efforts of all U.S. plants sustainable production commitment to obtain ISO 14001:2015 (Environmental Management) cert ISO 50001:2018 (Energy Management) certification, planned this year.
The Melrose Park team is passionate about our “caring for life” philosophy and bringing value to our customers and their patients through high-quality products. We are excited to learn about your contract manufacturing needs and be Your Partner for Solutions!